Skip to Main Content

Paper Details

OLIG2 Is a Determinant for the Relapse of MYC-Amplified Medulloblastoma.
Clin Cancer Res
5
2022
+, CRISPR, CT-179, MB, MB tumors, MYC, MYC-Amplified Medulloblastoma, MYC-amplified MB, MYC-amplified MB PDX models, MYC-amplified medulloblastoma, Myc, OLIG2, OLIG2 protein, OLIG2- tumor cells, PDX lines, PDX models, Patients, cerebellar tumor, mouse, mouse Myc-driven, patient, primary tumors, radioresistant tumor cells, relapsed tumors, resistant tumor cells, tumor, tumor cells, tumors
Author NameAffiliation
Brian R RoodCenter for Cancer and Immunology, Brain Tumor Institute
Brian R RoodCenter for Cancer and Immunology, Brain Tumor Institute
Roger J PackerCenter for Cancer and Immunology, Brain Tumor Institute
Roger J PackerCenter for Cancer and Immunology, Brain Tumor Institute
  • 1 - 4

Datasets

Release 1.2